The Globe and Mail reports in its Friday, Oct. 2, edition that Raymond James analyst Stephen Boland has reiterated his "market perform" recommendation for Dye & Durham. The Globe's David Leeder writes that Mr. Boland slashed his share target by $2.25 to $1.75. Analysts on average target the shares at $4.25. Mr. Boland says in a note: "While shares reacted sharply to a better-than-feared 4Q26, we caution against extrapolating one quarter of improved fundamentals. Dye & Durham now appears to have a credible path to remaining a going concern, but the margin for error remains slim, and each quarter will need to demonstrate revenue stability, cost discipline and cash generation. Under our estimates, stable to low-single-digit top-line growth supports sufficient liquidity and deleveraging, with net debt/EBITDA declining to 5.1 times by FYE27 from 6.4 times currently. This would provide meaningful breathing room ahead of the next refinancing wall, beginning with the $160-million convertible debentures due November, 2028, followed by the $509-million (U.S.) Senior Secured Notes in April, 2029. ... We believe solvency will remain the central question surrounding Dye & Durham absent a sale at a favorable valuation."